<DOC>
	<DOCNO>NCT03004209</DOCNO>
	<brief_summary>This study evaluate efficacy erythropoietin refractory autoimmune encephalitis . Ten patient receive 100 IU/kg erythropoietin 3 time week 12 week .</brief_summary>
	<brief_title>Effect Erythropoietin Refractory Autoimmune Encephalitis Patients</brief_title>
	<detailed_description>Erythropoietin improve refractory autoimmune encephalitis . Erythropoietin tissue-protective effect via activation Janus kinase ( JAK ) -2 , signal transducer activator transcription ( STAT ) -5 pathway NF-kappa B pathway . The activation JAK-2 STAT-5 promote hemoglobin synthesis facilitate cell cycle progression . Also , NF-kappa B pathway inhibition regulate pro-inflammatory cytokine production . We expect erythropoietin may lead improve symptom outcome autoimmune encephalitis .</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Hashimoto Disease</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Clinically diagnose autoimmune encephalitis Ineffective 1st line treatment ( e.g . steroid IV , IVIg ) 2nd line treatment ( e.g . Rituximab cyclophosphamide ) Hemoglobin &gt; 12g/dL Hematochrit &gt; 36 % Thrombocytosis &gt; 750K AST ALT &gt; 120 HIV ( + ) Allergic reaction upon erythropoietin Uncontrolled hypertension mRS autoimmune encephalitis &gt; 3 Breast feeding pregnancy History ischemic stroke pulmonary thrombosis Refuse enrol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Erythropoietin</keyword>
	<keyword>Autoimmune encephalitis</keyword>
</DOC>